TOI Oncology Institute Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TOI

Price (delayed)

$1.19

Market cap

$88.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.92

Enterprise value

$174.62M

Highlights
TOI's revenue is up by 28% year-on-year and by 4.6% since the previous quarter
Oncology Institute's net income has increased by 10% QoQ
The gross profit is up by 14% year-on-year but it is down by 2.1% since the previous quarter
TOI's equity has dropped by 54% year-on-year and by 21% since the previous quarter
The quick ratio has contracted by 14% from the previous quarter and by 6% YoY
Sector: Healthcare
Industry: Medical Care Facilities

Key stats

What are the main financial stats of TOI
Market
Shares outstanding
74.31M
Market cap
$88.43M
Enterprise value
$174.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.54
Price to sales (P/S)
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.54
Earnings
Revenue
$324.24M
EBIT
-$61.14M
EBITDA
-$55.26M
Free cash flow
-$40.88M
Per share
EPS
-$0.92
Free cash flow per share
-$0.55
Book value per share
$0.77
Revenue per share
$4.4
TBVPS
$2.5
Balance sheet
Total assets
$209.24M
Total liabilities
$152.22M
Debt
$119.68M
Equity
$57.03M
Working capital
$108.71M
Liquidity
Debt to equity
2.1
Current ratio
4.12
Quick ratio
3.62
Net debt/EBITDA
-1.56
Margins
EBITDA margin
-17%
Gross margin
18.4%
Net margin
-20.9%
Operating margin
-23.8%
Efficiency
Return on assets
-30.4%
Return on equity
-87%
Return on invested capital
-24%
Return on capital employed
-35%
Return on sales
-18.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TOI stock price

How has the Oncology Institute stock price performed over time
Intraday
-3.25%
1 week
-7.03%
1 month
-19.59%
1 year
130.26%
YTD
-41.67%
QTD
-24.68%

Financial performance

How have Oncology Institute's revenue and profit performed over time
Revenue
$324.24M
Gross profit
$59.57M
Operating income
-$77.02M
Net income
-$67.88M
Gross margin
18.4%
Net margin
-20.9%
TOI's revenue is up by 28% year-on-year and by 4.6% since the previous quarter
Oncology Institute's operating margin has increased by 27% YoY and by 15% from the previous quarter
The gross profit is up by 14% year-on-year but it is down by 2.1% since the previous quarter
The company's net margin rose by 14% QoQ

Growth

What is Oncology Institute's growth rate over time

Valuation

What is Oncology Institute stock price valuation
P/E
N/A
P/B
1.54
P/S
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.54
The EPS has contracted by 11% from the previous quarter
TOI's equity has dropped by 54% year-on-year and by 21% since the previous quarter
The stock's P/B is 18% more than its last 4 quarters average of 1.3
TOI's revenue is up by 28% year-on-year and by 4.6% since the previous quarter
The P/S is 10% less than the last 4 quarters average of 0.3

Efficiency

How efficient is Oncology Institute business performance
The ROS has grown by 10% from the previous quarter
The company's return on equity fell by 9% QoQ
The ROA is up by 4.7% since the previous quarter

Dividends

What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOI.

Financial health

How did Oncology Institute financials performed over time
The total assets is 37% more than the total liabilities
The total assets has contracted by 20% YoY and by 4.2% from the previous quarter
The quick ratio has contracted by 14% from the previous quarter and by 6% YoY
The company's debt is 110% higher than its equity
The debt to equity has soared by 139% YoY and by 29% from the previous quarter
TOI's equity has dropped by 54% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.